Amalgamated Bank Has $995,000 Stake in Sotera Health (NASDAQ:SHC)

Amalgamated Bank lifted its position in shares of Sotera Health (NASDAQ:SHC) by 3.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 72,715 shares of the company’s stock after purchasing an additional 2,368 shares during the quarter. Amalgamated Bank’s holdings in Sotera Health were worth $995,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the business. Louisiana State Employees Retirement System grew its holdings in shares of Sotera Health by 20.5% during the third quarter. Louisiana State Employees Retirement System now owns 42,400 shares of the company’s stock worth $708,000 after buying an additional 7,200 shares in the last quarter. Wealth Enhancement Advisory Services LLC acquired a new stake in shares of Sotera Health in the third quarter valued at approximately $850,000. State of Alaska Department of Revenue increased its holdings in shares of Sotera Health by 31.7% in the third quarter. State of Alaska Department of Revenue now owns 17,760 shares of the company’s stock valued at $296,000 after purchasing an additional 4,270 shares during the last quarter. New York State Teachers Retirement System lifted its position in Sotera Health by 3.5% during the third quarter. New York State Teachers Retirement System now owns 53,500 shares of the company’s stock worth $893,000 after acquiring an additional 1,800 shares during the last quarter. Finally, Capital Performance Advisors LLP bought a new stake in Sotera Health in the 3rd quarter valued at $91,000. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Trading Down 6.3 %

Shares of SHC opened at $11.68 on Tuesday. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. Sotera Health has a 52-week low of $10.71 and a 52-week high of $17.08. The firm has a market cap of $3.31 billion, a price-to-earnings ratio of 46.72 and a beta of 1.91. The business’s fifty day moving average is $13.42 and its 200-day moving average is $14.48.

Analyst Ratings Changes

SHC has been the topic of a number of analyst reports. Barclays decreased their target price on shares of Sotera Health from $17.00 to $16.00 and set an “overweight” rating on the stock in a research report on Friday. Royal Bank of Canada reissued an “outperform” rating and set a $17.00 target price on shares of Sotera Health in a report on Thursday, November 21st. Citigroup raised their price target on Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, November 6th. Finally, The Goldman Sachs Group began coverage on shares of Sotera Health in a research report on Friday, December 6th. They set a “neutral” rating and a $14.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, Sotera Health has an average rating of “Moderate Buy” and an average price target of $15.92.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.